Physician profile
Patrick L Klimczyk
NPI 1700923026
$338.49
in general payments reported to CMS, 2019-2025
8 companies · $106 in 2025
The $106 reported for 2025 was more than what 75% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $41.44 · 2024: $191 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $113.07 | 2023-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $57.64 | 2024-2025 | Simponi Aria, Tremfya, Simponi |
| Boston Scientific Corporation | $42.49 | 2024 | Watchman Flx |
| Abbvie INC. | $37.08 | 2024-2025 | |
| Lilly USA, LLC | $29.22 | 2024 | Omvoh |
| Rayner Intraocular Lenses Limited | $27.79 | 2025 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Intercept Pharmaceuticals, INC. | $16.16 | 2024 | |
| Bausch & Lomb Americas INC. | $15.04 | 2024 | Envista Mx60 Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Klimczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.